Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963983 | Vaccine | 2015 | 67 Pages |
Abstract
Most influenza vaccines are generally safe, but influenza vaccines can cause rare serious adverse events. Some adverse events, such as fever and febrile seizures, are more common in children than adults. There can be differences in the safety of vaccines in different populations due to underlying differences in genetic predisposition to the adverse event. Live attenuated vaccines have not been studied adequately in children under 2 years of age to determine the risks of adverse events; more studies are needed to address this and several other priority safety issues with all influenza vaccines in children. All vaccines intended for use in children require safety testing in the target age group, especially in young children. Safety of one influenza vaccine in children should not be extrapolated to assumed safety of all influenza vaccines in children. The low rates of adverse events from influenza vaccines should not be a deterrent to the use of influenza vaccines because of the overwhelming evidence of the burden of disease due to influenza in children.
Keywords
ORSMMRVSDTIVADEMSCCsAIDPEAEDTaPIRRVAERSECDCHAIGBSLAIVAcute inflammatory demyelinating polyradiculoneuropathyMSLQIVDTwPIgMIgGIgEMeasles mumps rubella VaccineMF59CDCEMAAMSANPCV13AS03IIVInflammatory arthritisMultiple sleep latency testexperimental autoimmune encephalomyelitisacute disseminated encephalomyelitisInfluenzaEuropean Medicines agencyMRIAMANVaccine safetyVaccine Safety DatalinkImmunoglobulin Eimmunoglobulin Gimmunoglobulin MRelative incidenceACIPFeverfebrile seizuresImmune thrombocytopeniaMagnetic resonance imagingcomputerized tomographyNarcolepsyRelative riskCNSSelf-controlled case seriesGuillain-Barré syndromecytomegalovirusCMVcentral nervous systemVaccine Adverse Event Reporting SystemAdverse eventsconfidence intervalsBell's palsyMyalgiaCSFCerebrospinal fluidEuropean Centre for Disease Prevention and ControlPrismhemagglutination inhibitionMultiple sclerosisMalaiseodds ratioincidence rate ratiosacute motor axonal neuropathyNacihemagglutininITPinfluenza vaccineInactivated influenza vaccinelive attenuated influenza vaccinepolymerase chain reactionPCRHypersensitivity reactionstransverse myelitisAdvisory Committee on Immunization Practices
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Neal A. Halsey, Kawsar R. Talaat, Adena Greenbaum, Eric Mensah, Matthew Z. Dudley, Tina Proveaux, Daniel A. Salmon,